Prelude Therapeutics

NASDAQ: PRLD · Real-Time Price · USD
0.84
-0.10 (-11.11%)
At close: Aug 15, 2025, 3:59 PM
0.87
4.05%
After-hours: Aug 15, 2025, 04:54 PM EDT

Prelude Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-127.83M -127.17M -131.52M -129.85M -125.55M -121.83M -117.4M -116.75M -113.69M -115.44M -119.64M -120.37M -119.86M -111.69M -98.1M -84.17M -68.72M
Depreciation & Amortization
-1.91M -1.92M -2.07M 1.49M 1.32M 1.17M 1.2M 1.26M 1.29M 1.32M 1.25M 1.18M 1.06M 915K 758K 634K 570K
Stock-Based Compensation
19.63M 21.34M 23.48M 18.18M 24.91M 25.62M 25.55M 25.28M 24.57M 25.14M 25.07M 25.66M 23.87M 20.93M 18.28M 12.72M 9.11M
Other Working Capital
1.85M 982K 2.69M 2.88M -4.74M -8.21M -9.9M -11.86M -7.3M 1.28M 2.39M 1.2M -233K -278K -1.97M 3.48M 3.52M
Other Non-Cash Items
1.99M 6.17M 7.34M 10.69M 6.14M 1.49M 1.14M 2.11M 3.14M 4.31M 4.45M 3.38M 2.21M 1.33M 939K 583.8K 295K
Deferred Income Tax
n/a n/a -1.07M -2.67M -3.03M -3.03M -1.96M -359K n/a n/a 1.01M 1.36M 1.36M 1.36M 356K n/a n/a
Change in Working Capital
2.62M 4.29M 3.72M 3.65M -6.75M -10.48M -14.95M -12.71M -7.28M 932K 1.35M 937K 2.07M 3.63M 5.09M 6.83M 6.35M
Operating Cash Flow
-105.33M -102.89M -105.72M -104.11M -108.72M -107.06M -106.41M -101.17M -91.97M -83.73M -86.5M -87.84M -89.28M -83.53M -72.68M -63.41M -52.4M
Capital Expenditures
-522K -764K -1.84M -2.37M -2.99M -3.51M -2.78M -3.1M -2.88M -3.02M -2.92M -2.67M -2.29M -2.32M -2.35M -1.87M -1.53M
Cash Acquisitions
n/a n/a -8.87K -24.5K 49.94K 31.13K 38.25K 31.36K -61.02K -42.21K -40.46K -17.94K n/a n/a n/a n/a n/a
Purchase of Investments
-56.67M -52.69M -104.75M -106.87M -219.93M -221.63M -195.5M -220.22M -126.41M -119.22M -87.48M -288.62M -261.48M -261.48M -259.97M n/a n/a
Sales Maturities Of Investments
178.34M 143.65M 182.4M 189.36M 201.5M 190.5M 157.25M 188.85M 187.43M 203.93M 168.93M 87.58M 42.5M n/a n/a n/a n/a
Other Investing Acitivies
26.48K 57.99K 66.85K 82.49K -18.43K -31.13K -38.25K -31.36K 61.02K 84.71K 81.45K -259.91M -259.93M -259.97M -259.97M n/a n/a
Investing Cash Flow
121.16M 90.19M 75.81M 80.12M -21.42M -34.65M -41.03M -34.47M 58.14M 81.69M 78.53M -203.71M -221.27M -263.8M -262.33M -1.87M -1.53M
Debt Repayment
-454K -299K -148K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -67K -163K
Common Stock Repurchased
16.00 n/a n/a -34 -16 n/a n/a n/a n/a n/a n/a n/a n/a n/a -1.29M -1.29M -1.29M
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
188K 179K 363K 330K 111.61M 111.36M 111.21M 111.37M 393K 815K 2.61M 3.18M 3.24M 3.47M 1.51M 861K 470K
Financial Cash Flow
-266K -120K 25.15M 25.37M 136.65M 136.4M 111.31M 111.37M 393K 815K 2.61M 3.18M 3.24M 164.9M 161.64M 378.68M 378.19M
Net Cash Flow
15.56M -12.82M -4.76M 1.38M 6.51M -5.31M -36.13M -24.26M -33.43M -1.22M -5.36M -288.37M -307.31M -182.44M -173.37M 313.4M 324.26M
Free Cash Flow
-105.85M -103.65M -107.56M -106.48M -111.71M -110.58M -109.19M -104.27M -94.84M -86.75M -89.43M -90.5M -91.57M -85.85M -75.03M -65.28M -53.93M